Entry Detail



General Information

Database ID:exR0080661
RNA Name:RPS29
RNA Type:mRNA
Chromosome:chr14
Starnd:-
Coordinate:
Start Site(bp):49570984End Site(bp):49599164
External Links:ENSG00000213741



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AASDHPPT
chr11
106075501
106098699
+
ABCE1
chr4
145098288
145129524
+
ABCF2
chr7
151207837
151227166
-
AC006538.2
chr19
2717769
2740048
-
AC007192.1
chr19
18153158
18178117
+
AC011448.1
chr19
19516227
19536076
+
AC023055.1
chr12
55757275
55827546
-
AC098484.3
chr1
42767292
42794493
+
AC099811.2
chr17
42119674
42154916
-
AC124312.1
chr15
24955034
25000276
+
AC138811.2
chr16
18788063
18801519
-
AC245033.1
chr15
82536788
82573194
-
ACSS1
chr20
25006230
25058980
-
ACTB
chr7
5527148
5563784
-
ACTG1
chr17
81509971
81523847
-
ACTR1A
chr10
102461881
102502712
-
ACTR3
chr2
113890063
113962596
+
AGO2
chr8
140520156
140635633
-
AHSA1
chr14
77457870
77469472
+
AK4
chr1
65147549
65232145
+
AL049844.3
chr6
143857318
143938471
+
AL132780.3
chr14
22946270
22982258
-
AL139353.1
chr14
31334312
31457441
-
ALAS1
chr3
52198086
52214327
+
ALDH18A1
chr10
95605941
95656711
-
ALDOA
chr16
30064164
30070457
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-182-5p
chr7
129770447
129770470
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC007218.1
chr16
9666885
9676843
-
AC010618.3
chr19
17488990
17511889
-
AC016876.2
chr17
7581964
7584086
-
AC064802.1
chr8
114282067
114295839
+
AC087190.3
chr16
9104848
9113181
+
AC104793.1
chr4
161378953
161388417
+
AC245033.4
chr15
82533175
82540008
-
AL031595.3
chr22
44139365
44153626
+
AL117378.1
chr6
131901963
131920565
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA